Detalhe da pesquisa
1.
Optimal Post-Remission Consolidation Therapy in Patients with AML.
Acta Haematol
; 147(2): 147-158, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008085
2.
Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.
Hematol Oncol
; 41(4): 753-761, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081742
3.
Transfusion support in COVID-19 patients: Impact on hospital blood component supply during the outbreak.
Transfusion
; 61(2): 361-367, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33146420
4.
Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease.
Am J Hematol
; 96(8): E288-E291, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939851
5.
Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML.
Blood Adv
; 8(2): 343-352, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039513
6.
Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia.
Front Oncol
; 14: 1394648, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38756667
7.
The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid.
Leuk Res
; 101: 106518, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33571876